Moreover, increased inflammation promotes protein degradation in T2D by upregulating the expression levels of atrogin-1 and muscle RING finger-1 (MuRF1), which are major factors of the ubiquitin–proteasome pathway in muscles [9]. The gene discussed is FBXO32; the disease is type 2 diabetes mellitus.